Search
Cybin Inc
CYBNAdd to Watchlist
8.280USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
390.73MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-01-02The current earnings forecast score of Cybin Inc is 8.29, ranking 143 out of 403 in the Biotechnology & Medical Research industry. The average price target is 51.50, with a high of 114.00 and a low of 30.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
43.000
Target Price
+589.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Cybin Inc
CYBN
9
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cybin Inc's price target?
Analysts forecast that Cybin Inc's price target is USD 51.50, with the highest forecast at USD 114.00 and the lowest forecast at USD 30.00.
How have Cybin IncCYBN's recent earnings per share performed?
The market expectation was USD -0.68, while Cybin IncCYBN's earnings per share (EPS) for the previous quarter was USD -0.73. EPS for the next quarter is expected at USD -0.61.
What is the analyst rating for Cybin Inc?
Based on the ratings of Cybin Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.